AJP - Renal Physiology, Vol 264, Issue 1 74-F78, Copyright © 1993 by American Physiological Society

ARTICLES

Renal effects of acute endothelial-derived relaxing factor blockade are not mediated by angiotensin II

C. Baylis, K. Engels, L. Samsell and P. Harton
Department of Physiology, West Virginia University, Morgantown.

The renal responses to acute blockade of the endothelial-derived relaxing factor (EDRF) resemble the renal actions of angiotensin II (ANG II), and the present studies were conducted to establish what role, if any, the endogenous renin-angiotensin system plays in mediating the renal response to acute EDRF blockade. These studies were conducted in the conscious chronically catheterized rat. In control experiments we observed that acute blockade of ANG II synthesis with converting-enzyme inhibition (CEI) led to a fall in blood pressure (BP) and a slight renal vasodilation but no significant change in glomerular filtration rate (GFR) or renal plasma flow (RPF). Urine flow and sodium excretion were unchanged by CEI. Use of the nonpeptide ANG II receptor antagonist losartan had no effect on BP, renal vascular resistance (RVR), GFR, or RPF; however, urine flow and sodium excretion did rise significantly. Because of the high specificity of losartan, this suggests that, in the normal conscious rat, endogenous ANG II does not control renal vascular tone but does enhance renal sodium reabsorption. ANG II blockade with either CEI or losartan had little effect on BP and no effect on the renal hemodynamic responses to acute EDRF blockade. The marked natriuretic and diuretic response to acute EDRF blockade persists during concomitant losartan but is abolished by CEI. These studies suggest that in the conscious rat the renal hemodynamic response to EDRF blockade is not mediated by endogenous ANG II.

This article has been cited by other articles:

				A. Riggleman, J. Harvey, and C. Baylis Endothelin Mediates Some of the Renal Actions of Acutely Administered Angiotensin II Hypertension, July 1, 2001; 38(1): 105 - 109. [Abstract] [Full Text] [PDF]

				S. Xiao, A. Erdely, L. Wagner, and C. Baylis Uremic levels of BUN do not cause nitric oxide deficiency in rats with normal renal function Am J Physiol Renal Physiol, June 1, 2001; 280(6): F996 - F1000. [Abstract] [Full Text] [PDF]

				J. Schnermann, Y. G Huang, and J. P Briggs Angiotensin II blockade causes acute renal failure in eNOS-deficient mice Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S199 - S203. [Abstract] [PDF]

				L. Raij Workshop: Hypertension and Cardiovascular Risk Factors : Role of the Angiotensin II-Nitric Oxide Interaction Hypertension, February 1, 2001; 37(2): 767 - 773. [Abstract] [Full Text] [PDF]

				R. Komers, T. T. Oyama, J. G. Chapman, K. M. Allison, and S. Anderson Effects of Systemic Inhibition of Neuronal Nitric Oxide Synthase in Diabetic Rats Hypertension, February 1, 2000; 35(2): 655 - 661. [Abstract] [Full Text] [PDF]

				D. L. Mattson and F. Wu Nitric Oxide Synthase Activity and Isoforms in Rat Renal Vasculature Hypertension, January 1, 2000; 35(1): 337 - 341. [Abstract] [Full Text] [PDF]

				B. Braam Renal endothelial and macula densa NOS: integrated response to changes in extracellular fluid volume Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1551 - R1561. [Abstract] [Full Text] [PDF]

				F. Wu, F. Park, A. W. Cowley Jr., and D. L. Mattson Quantification of nitric oxide synthase activity in microdissected segments of the rat kidney Am J Physiol Renal Physiol, June 1, 1999; 276(6): F874 - F881. [Abstract] [Full Text] [PDF]

				X.-Z. Zhang and C. Baylis Endothelin mediates renal vascular memory of a transient rise in perfusion pressure due to NOS inhibition Am J Physiol Renal Physiol, April 1, 1999; 276(4): F629 - F634. [Abstract] [Full Text] [PDF]

				T. Kriston, R. C. Venuto, C. Baylis, and G. Losonczy Hemodynamic and renal effects of U-46619, a TXA2/PGH2 analog, in late-pregnant rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R831 - R837. [Abstract] [Full Text] [PDF]

				C. Baylis, J. Harvey, B. R. Santmyire, and K. Engels Pressor and Renal Vasoconstrictor Responses to Acute Systemic Nitric Oxide Synthesis Inhibition Are Independent of the Sympathetic Nervous System and Angiotensin II J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 693 - 698. [Abstract] [Full Text]

				M. C. Ortiz, L. A. Fortepiani, F. M. Ruiz-Marcos, N. M. Atucha, and J. Garcia-Estan Role of AT1 receptors in the renal papillary effects of acute and chronic nitric oxide inhibition Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R760 - R766. [Abstract] [Full Text] [PDF]

				M. T. Llinas, J. D. Gonzalez, F. Rodriguez, E. Nava, S. Taddei, and F. J. Salazar Renal Changes Induced by Nitric Oxide and Prostaglandin Synthesis Reduction : Effects of Trandolapril and Verapamil Hypertension, February 1, 1998; 31(2): 657 - 664. [Abstract] [Full Text] [PDF]

				X. Deng, W. J. Welch, and C. S. Wilcox Role of Nitric Oxide in Short-term and Prolonged Effects of Angiotensin II on Renal Hemodynamics Hypertension, May 1, 1996; 27(5): 1173 - 1179. [Abstract] [Full Text]

				A. W. Cowley Jr, D. L. Mattson, S. Lu, and R. J. Roman The Renal Medulla and Hypertension Hypertension, April 1, 1995; 25(4): 663 - 673. [Abstract] [Full Text]

				C. Qiu, K. Engels, L. Samsell, and C. Baylis Renal Effects of Acute Amino Acid Infusion in Hypertension Induced by Chronic Nitric Oxide Blockade Hypertension, January 1, 1995; 25(1): 61 - 66. [Abstract] [Full Text]

				R. Kramp, P. Fourmanoir, and N. Caron Endothelin resets renal blood flow autoregulatory efficiency during acute blockade of NO in the rat Am J Physiol Renal Physiol, December 1, 2001; 281(6): F1132 - F1140. [Abstract] [Full Text] [PDF]